PubRank
Search
About
Valle Palomo
Author PubWeight™ 9.15
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.
ACS Chem Neurosci
2012
0.96
2
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
J Immunol
2013
0.93
3
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
J Med Chem
2011
0.90
4
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice.
Neuropharmacology
2012
0.85
5
Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.
ACS Chem Neurosci
2014
0.85
6
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury.
PLoS One
2011
0.82
7
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
ACS Chem Neurosci
2012
0.79
8
5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin.
Eur J Pharm Sci
2012
0.78
9
T cells control the generation of nanomolar-affinity anti-glycan antibodies.
J Clin Invest
2017
0.78
10
UV and sunlight driven photoligation of quantum dots: understanding the photochemical transformation of the ligands.
J Am Chem Soc
2015
0.77
11
The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury.
J Neurochem
2012
0.77